SOBI Acquires European Rights to Dongbao Anemia Drug

Swedish Orphan Biovitrum has in-licensed European marketing rights to Iron Sucrose Rechon, an anemia drug, from Dongbao Group’s subsidiary, Rechon Life Science Group, a contract manufacturer located in Malmo, Sweden. Sobi will pay a $1.7 million regulatory milestone to Rechon, plus a transfer price and a royalty on net sales. More details.... Stock Symbols: (STO: SOBI) (SHEX: 600867)